Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
D&C Biotechnology Inc logo — Bio Healthcare, In vitro diagnosis

D&C Biotechnology Inc

Bio Healthcare, In vitro diagnosis

Founded 2021 Korea South Korea South 4 employees Seed Total: $1.50B Biotechnology, Medical Devices

General Information

Company Name D&C Biotechnology Inc
Founded Year 2021
Location Korea South Korea South
Employees 4
Industries Biotechnology, Medical Devices
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with D&C Biotechnology Inc. To contact D&C Biotechnology Inc, visit dncbiotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does D&C Biotechnology Inc compare?

A PDF of D&C Biotechnology Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting D&C Biotechnology Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About D&C Biotechnology Inc

D&C Biotechnology Inc is a South Korean startup that focuses on Biotechnology and specializes in the development of in vitro diagnostic medical device solutions. The company, founded in 2021, is driven by a vision to address the complexities in the global medical landscape with innovative ideas and technologies. The company's slogan, "Bio Healthcare, In vitro diagnosis," reflects its commitment to contribute to global public health through early disease detection and prevention. D&C Biotechnology aims to achieve this by leveraging deep-tech-based in vitro diagnostic devices to accurately and efficiently solve diverse medical challenges. In line with its vision, the startup recently secured a significant KRW1.00B Seed Round investment on 03 July 2023. Notable investors in this round include Technology Holdings, Future Science and Technology Holdings, Quantum Financing & Acquisition, Hallym University, and KFFI. This investment underscores the confidence that prominent entities have in D&C Biotechnology's potential to make a significant impact in the biotechnology space. With its strategic focus on developing innovative solutions for in vitro diagnosis, D&C Biotechnology Inc. is well-positioned to make valuable contributions to the global healthcare industry.

Business keywords: in vitro diagnosis, innovative technology, disease detection, prevention, public health, deep-tech, global settings

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round KRW1.00B 5
Technology Holdings Future Science and Technology Holdings
Technology Holdings, Future Science and Technology Holdings +3
03 Jul 2023
Seed Round KRW500.00M 3
ROWE Partners History Venture Investment Future Science and Technology Holdings
ROWE Partners, History Venture Investment +1
16 Feb 2023

D&C Biotechnology Inc Alternatives & Competitors

View All Alternatives
D&C Biotechnology Inc vs
CardioSignal by Precordior
CardioSignal by Precordior Finland

CardioSignal is developing a disruptive mobile application-based technology to improve the detection...

Non Equity Assistance
30 employees
Biotechnology, Health Care
D&C Biotechnology Inc vs
GreenMark Biomedical Inc
GreenMark Biomedical Inc United States

GreenMark is a healthcare company that enables dentists to preserve teeth through early diagnosis an...

7 employees
Biotechnology, Health Care
D&C Biotechnology Inc vs
Medo.ai
Medo.ai Canada

Ultrasound made simple.

Convertible Note
6 employees
AI, Biotechnology
View all alternatives

FAQ About D&C Biotechnology Inc

Bio Healthcare, In vitro diagnosis
D&C Biotechnology Inc was founded in 2021.
D&C Biotechnology Inc is headquartered in Korea South.
D&C Biotechnology Inc operates in Biotechnology and Medical Devices. Its work centres on in vitro diagnosis, innovative technology, disease detection and prevention.
D&C Biotechnology Inc has approximately 4 employees.
D&C Biotechnology Inc has completed 2 funding rounds, raising a total of $1.50B. The latest funding stage is Seed.
Top alternatives and competitors to D&C Biotechnology Inc include CardioSignal by Precordior, GreenMark Biomedical Inc, Medo.ai, Preventicus GmbH, Cyted Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
D&C Biotechnology Inc and CardioSignal by Precordior are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for D&C Biotechnology Inc, https://bouncewatch.com/company/dc-biotechnology-inc, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout